Adverse reaction to Coartem (artemether/lumefantrine) resulting in oculogyric crisis
Abstract Background Artemether/lumefantrine (AL), sold under the brand name Coartem, is the most common artemisinin-based combination therapy for the treatment of malaria. Drug-induced oculogyric crisis is a neurological disorder characterized by frequent upward deviations of the eye. In the literat...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-05-01
|
Series: | Maxillofacial Plastic and Reconstructive Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40902-021-00300-y |